Catalyst Wire Dossier Catalyst Wire Dossier

VX-152

· Vertex Pharmaceuticals Incorporated
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VX-152, covering 2021-01-28 to 2021-01-28. Get the full timeline:

Most recent: Clinical Trial Update: A Study Evaluating the Safety of VX-152 Combination Therapy in Adults With Cystic Fibrosis [Phase 2]

See pricing